Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial‐onset seizures: A randomized historical‐control phase III study based in North America

Publisher： John Wiley & Sons Inc

E-ISSN： 1528-1167|56|4|546-555

ISSN： 0013-9580

Source： EPILEPSIA, Vol.56, Iss.4, 2015-04, pp. : 546-555

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial‐onset seizures: Results of a phase III, double‐blind, randomized, placebo‐controlled trial

By  

EPILEPSIA, Vol. 56, Iss. 2, 2015-02 ,pp. : 244-253

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized, double‐blind, placebo‐controlled, multicenter, parallel‐group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial‐onset seizures

By  

EPILEPSIA, Vol. 56, Iss. 12, 2015-12 ,pp. : 1890-1898

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of eslicarbazepine acetate versus controlled‐release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double‐blind, randomized, parallel‐group, multicenter study

By  

EPILEPSIA, Vol. 59, Iss. 2, 2018-02 ,pp. : 479-491

John Wiley & Sons Inc

Access to resources Recommend Favorite

Once‐daily USL255 as adjunctive treatment of partial‐onset seizures: Randomized phase III study

By  

EPILEPSIA, Vol. 55, Iss. 7, 2014-07 ,pp. : 1077-1087

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term safety of perampanel and seizure outcomes in refractory partial‐onset seizures and secondarily generalized seizures: Results from phase III extension study 307

By  

EPILEPSIA, Vol. 55, Iss. 7, 2014-07 ,pp. : 1058-1068

John Wiley & Sons Inc

Access to resources Recommend Favorite